Consultation opens on guide to China for Australian medtech companies


Thursday, 20 November, 2014

AusBiotech and an expert advisory panel have developed a draft ‘China Guide’ for Australian medtech companies and AusBiotech is now seeking comment.

The guide aims to assist small to medium-sized Australian medical technology companies (medical devices and diagnostics) that are seeking to engage with and in China. It is part of a larger project which has received funding support from the Australian Trade Commission under the Asian Business Engagement grants program.

The guide and the broader project seek to facilitate medtech trade and partnership with China by breaking down the information barriers for Australian companies about intellectual property (IP) management in China and the types of business structures that are possible for Australian companies engaging in China. The guide includes introductory information, including business and cultural details, and the regulatory context that a medtech company may consider in a strategy for China. The guide does not intend to be exhaustive or to take the place of professional advice. Instead, it is to serve as a starting point for Australian companies.

The consultation closes 27 February 2015 and the completed China Guide will be officially launched at AusMedtech 2015 (29-30 April 2015).

How to contribute to the consultation

Comments are invited from interested parties. Reviewers may wish to consider the following questions:

  • Is there any section or information that is superfluous/missing?
  • Is the flow/structure appropriate?
  • Does any section need re-wording to increase clarity?
  • Is any information now redundant, factually incorrect or superseded?

Comments should be specific and tracking changes is encouraged, so that your intention is clearly understood. The draft Word document can be accessed via the Project Manager (details below) or it may be found here.

Please provide comments, submissions and/or enquiries to Project Manager Lorraine Chiroiu, AusBiotech, by emailing lchiroiu@ausbiotech.org or calling (03) 9828 1414 or 0429 801 118.

Related News

Shingles vaccine may reduce risk of heart attack and stroke 

Vaccination with either the recombinant herpes zoster vaccine or the live-attenuated zoster...

Perioperative trial offers insights into brain cancer treatment

Victorian brain cancer researchers have used an innovative process to learn how a new drug...

New molecular mechanism found for depression

Depression may not only result from simple neuronal damage but can also arise from the...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd